相关实验视频
Updated: Jun 24, 2025

Cecal Ligation Puncture Procedure
Published on: May 7, 2011
在败血症休克和CAP中,皮 + 皮可降低90天死亡率
1University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA (D.G.M.).
这项研究检查了是否添加fludrocortisone到hydrocortisone改善了由社区获得的肺炎引起的败血症休克的结果. 组合疗法没有显著降低这一患者亚组的死亡率.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 内分泌学 在内分泌学.
背景情况:
- 败血性休克是一种危及生命的疾病,通常需要血管压缩剂支持.
- 社区获得的肺炎是败血症和败血性休克的常见原因之一.
- 皮质类固醇有时用于败血性休克,但它们的最佳使用是有争议的.
研究的目的:
- 为了研究皮和皮联合治疗的疗效,在社区获得的肺炎的二次性败血性休克的患者.
- 分析APROCCHSS第三阶段随机试验中的患者子组.
主要方法:
- 一个第三阶段随机对照试验 (APROCCHSS) 的子组分析.
- 包括的患者因社区获得的肺炎而遭受了败血症休克.
- 治疗涉及皮质加皮质与标准护理.
主要成果:
- 与单独使用皮质相比,添加皮质和皮质并没有显著降低28天死亡率.
- 在二次结果中没有观察到显著差异,例如冲击分辨率或器官功能障碍.
- 这些发现表明,在这种特定的败血症休克群体中,矿物质皮质醇补充剂的益处有限.
结论:
- 联合皮松和皮松治疗与社区获得的肺炎相关的败血症休克患者的死亡率改善无关.
- 可能需要进一步的研究来确定可能受益于败血症中矿物质皮质醇治疗的子组.
更多相关视频
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
COPD: Management Using Bronchodilators and Corticosteroids
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: